SecBot SecBot
SECBOTREPLAY Home › Report › EVH

EVH · Evolent Health reported Q2 2026 revenue of $652.5M, up 46.9% YoY, but…

Evolent Health, Inc. · 8-K filed Aug 6, 2026 at 07:03 ET

At the news

MIXEDIMPACT 6/10

8-K filed Aug 6, 2026 at 07:03 ET

Evolent Health reported Q2 2026 revenue of $652.5M, up 46.9% YoY, but GAAP EPS was -$0.25, a miss vs the -$0.10 Street consensus. The company raised its full-year 2026 revenue guidance to $2.6-$2.7B and tightened its Adjusted EBITDA range to $120-$135M, while providing a bullish 2027 outlook of >25% revenue growth and $150M+ Adjusted EBITDA. However, the Medical Expense Ratio (MER) surged to 95.3% from 84.9% a year ago, signaling significant margin pressure in the Performance Suite, and operating cash flow remained negative.

  • Q2 2026 revenue of $652.5M, up 46.9% YoY from $444.3M.
  • GAAP EPS of -$0.25 missed the Street consensus of -$0.10.
  • Full-year 2026 revenue guidance raised to $2.6-$2.7B; Adjusted EBITDA guidance tightened to $120-$135M.
  • Management issued a 2027 outlook for >25% revenue growth and Adjusted EBITDA midpoint of at least $150M.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access